U.S. vaccine advisers are weighing whether boys and young men should be vaccinated against the human wart virus that causes a number of cancers, but some worry the vaccine is too costly to justify its use. Merck & Co’s Gardasil vaccine is approved for boys, safe and it would be cost-effective, CDC researchers and vaccine experts told a meeting of the Advisory Committee on Immunization Practices on Thursday. Some men would also benefit from the vaccine, including homosexuals and bisexuals, who are at risk of developing anal cancers and other conditions caused by the human papillomavirus, or HPV, the experts said. HPV infection is best known as the primary cause of cervical cancer, but it can also lead to cancers of the anus, penis, head and neck. Vaccinating men and boys could prevent some of these cancers. Currently, U.S. Centers for Disease Control and Prevention recommends Gardasil vaccinations for girls and women between the ages of 11 and 26. And while doctors are free to use the vaccine for preventing genital warts in boys and men ages 9 through 26, U.S. vaccine advisers last year declined to recommend routine vaccination for males. But they did make it available to boys… Read full this story
- Parental concerns rise over HPV vaccine: study
- Medical worker advises to inject HPV vaccine for preventing cervical cancer
- Experts support HPV vaccines in fight against cancer
- Experts support HPV vaccines in cancer fight
- Baby boy dies day after vaccination
- Free immunisation programme to receive more vaccines
- Vietnam's imported medicine costs US$777 million in 2007
- HCM City: two men receive death sentences for drug smuggling
- "Forest men" receive support to settle down
- Vietnam researching into incurable swine fever to develop vaccine
Should boys and men receive the HPV vaccine? Controversy that medicine is too costly have 288 words, post on www.nydailynews.com at October 29, 2010. This is cached page on Business Breaking News. If you want remove this page, please contact us.
